International Journal of Gynecological Cancer
Издатель: Elsevier · ISSN 1048-891X · 79 статей
- Artificial intelligence-assisted triage of cervical biopsies using the low-cost, 3D-printed OpenFlexure Microscope: a paired comparative feasibility study
- Not all artificial intelligence large language models are created equal: heterogeneous performance in therapeutic decision-making for recurrent epithelial ovarian cancer
- Gender inequalities in sexual health assessment after pelvic radiotherapy
- Follow-up after fertility-sparing surgery for cervical cancer: should human papillomavirus testing be used routinely? A narrative review
- Arterial embolization for hemorrhage control in gynecologic malignancies: a narrative review of current evidence and unresolved questions
- Treatment strategies for oligometastatic and oligorecurrent epithelial ovarian cancer: a narrative review
- Dexamethasone-associated hyperglycemia during chemotherapy in endometrial and ovarian cancer: a retrospective study
- Comparison of sentinel lymph node mapping with comprehensive lymphadenectomy in p53-mutated endometrial cancer: a prospective, multi-center, non-inferiority, open-label, de-escalation, randomized, controlled trial (Study Protocol - SENTIMETREP53)
- Decision-making in high-grade endometrial carcinoma when fertility preservation is not feasible
- Early-career voices in International Gynecologic Cancer Society: global perspectives on needs for members
- First robotic radical trachelectomy for cervical cancer using the Hugo RAS platform
- Minimally invasive lateral pelvic sidewall resection for nodal recurrence of high-grade endometrioid endometrial carcinoma
- Right subphrenic peritonectomy procedure without initial liver mobilization to facilitate complete macroscopic resection of tumor in advanced tubo-ovarian carcinoma
- Invasive complete hydatidiform mole
- Torsion of a borderline ovarian tumor in a pregnancy
- Beyond the number of cycles: lessons from the CHRONO trial in advanced ovarian cancer
- Rethinking adjuvant treatment intensification in early-stage cervical cancer after radical surgery
- #Jump4June: an opportunity to revisit the evaluation of post-menopausal bleeding
- Lymphovascular space invasion in cervical cancer: beyond the binary
- Personalized circulating tumor DNA–based minimal residual disease assessment for optimizing interval debulking surgery timing in advanced ovarian cancer: toward precision surgical oncology
- Is conization with lymph node dissection safe for International Federation of Gynecology and Obstetrics 2018 stage IB1 cervical cancer measuring 1 to 2 cm?
- Correspondence on “A prospective comparison of resectability scores to enhance preoperative decision-making in the primary management of advanced ovarian cancer: a Memorial Sloan Kettering Cancer Center Team Ovary study” by Kahn et al.
- Correspondence on “Multicenter validated machine learning model for cervical cancer based on HPV genotyping results” by Ziren Chen et al
- Correspondence on “Opportunistic salpingectomy during gynecologic and non-gynecologic abdominopelvic procedures for ovarian cancer primary prevention: A cost-effectiveness analysis” by Adjei et al
- Correspondence on “Incidence of ESR1 gene mutations among patients with endometrioid endometrial cancer” by Jang et al
- Correspondence on “Early administration of adjuvant chemotherapy for patients with advanced-stage malignant ovarian germ cell tumors is associated with an overall survival benefit” by Jang M et al
- Correspondence on “Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study” by Zhou et al
- Robotic approach for lymph nodal recurrence in ovarian cancer: lymphatic anatomy, vascular damage control, no-touch en-bloc resection.
- Transitioning Between Robotic Platforms in Endometrial Cancer Surgical Staging: A Propensity Score–Matched Comparison of Hugo™ RAS and Da Vinci® Xi
- Factors Associated with Brachytherapy Utilization and Comparative Effectiveness of External Beam Radiotherapy with or without Brachytherapy for Locally Advanced Cervical Cancer in India: A Target Trial Emulation Using National Cancer Registry Data